MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $65.96MP/E –Yield –
MediciNova total assets
Total assets on the balance sheet at the end of each period.
MediciNova's total assets was $40.43M at Jun 30, 2026. For fiscal 2025 it was $45.60M, down 18.4% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $87.41M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.60M | -18.4% |
| FY2024 | Dec 31, 2024 | $55.88M | -15.7% |
| FY2023 | Dec 31, 2023 | $66.27M | -10.6% |
| FY2022 | Dec 31, 2022 | $74.15M | -15.2% |
| FY2021 | Dec 31, 2021 | $87.41M | +15.9% |
| FY2020 | Dec 31, 2020 | $75.42M | -4.8% |
| FY2019 | Dec 31, 2019 | $79.21M | +2.6% |
| FY2018 | Dec 31, 2018 | $77.22M | +77.9% |
| FY2017 | Dec 31, 2017 | $43.42M | +9.1% |
| FY2016 | Dec 31, 2016 | $39.81M | +5.0% |
| FY2015 | Dec 31, 2015 | $37.91M | +39.0% |
| FY2014 | Dec 31, 2014 | $27.27M | -7.7% |
| FY2013 | Dec 31, 2013 | $29.55M | +51.0% |
| FY2012 | Dec 31, 2012 | $19.57M | -36.4% |
| FY2011 | Dec 31, 2011 | $30.79M | -57.8% |
| FY2010 | Dec 31, 2010 | $72.93M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $40.43M | -18.8% |
| Q1 FY2026 | Mar 31, 2026 | $42.70M | -18.6% |
| Q4 FY2025 | Dec 31, 2025 | $45.60M | -18.4% |
| Q3 FY2025 | Sep 30, 2025 | $47.58M | -18.1% |
| Q2 FY2025 | Jun 30, 2025 | $49.82M | -17.5% |
| Q1 FY2025 | Mar 31, 2025 | $52.43M | -16.6% |
| Q4 FY2024 | Dec 31, 2024 | $55.88M | -15.7% |
| Q3 FY2024 | Sep 30, 2024 | $58.12M | -14.7% |
| Q2 FY2024 | Jun 30, 2024 | $60.40M | -12.1% |
| Q1 FY2024 | Mar 31, 2024 | $62.89M | -11.6% |
| Q4 FY2023 | Dec 31, 2023 | $66.27M | -10.6% |
| Q3 FY2023 | Sep 30, 2023 | $68.14M | -13.1% |
| Q2 FY2023 | Jun 30, 2023 | $68.72M | -15.4% |
| Q1 FY2023 | Mar 31, 2023 | $71.13M | -15.5% |
| Q4 FY2022 | Dec 31, 2022 | $74.15M | -15.2% |
| Q3 FY2022 | Sep 30, 2022 | $78.39M | -14.4% |
| Q2 FY2022 | Jun 30, 2022 | $81.24M | -13.3% |
| Q1 FY2022 | Mar 31, 2022 | $84.18M | -12.4% |
| Q4 FY2021 | Dec 31, 2021 | $87.41M | +15.9% |
| Q3 FY2021 | Sep 30, 2021 | $91.62M | +18.5% |
| Q2 FY2021 | Jun 30, 2021 | $93.68M | +23.5% |
| Q1 FY2021 | Mar 31, 2021 | $96.10M | +24.8% |
| Q4 FY2020 | Dec 31, 2020 | $75.42M | -4.8% |
| Q3 FY2020 | Sep 30, 2020 | $77.29M | -1.2% |
| Q2 FY2020 | Jun 30, 2020 | $75.84M | -1.7% |
| Q1 FY2020 | Mar 31, 2020 | $77.01M | -2.0% |
| Q4 FY2019 | Dec 31, 2019 | $79.21M | +2.6% |
| Q3 FY2019 | Sep 30, 2019 | $78.22M | +1.2% |
| Q2 FY2019 | Jun 30, 2019 | $77.15M | -2.4% |
| Q1 FY2019 | Mar 31, 2019 | $78.55M | -0.1% |
| Q4 FY2018 | Dec 31, 2018 | $77.22M | +77.9% |
| Q3 FY2018 | Sep 30, 2018 | $77.28M | +92.7% |
| Q2 FY2018 | Jun 30, 2018 | $79.08M | +105.6% |
| Q1 FY2018 | Mar 31, 2018 | $78.66M | +110.2% |
| Q4 FY2017 | Dec 31, 2017 | $43.42M | +9.1% |
| Q3 FY2017 | Sep 30, 2017 | $40.11M | -1.6% |
| Q2 FY2017 | Jun 30, 2017 | $38.46M | – |
| Q1 FY2017 | Mar 31, 2017 | $37.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $39.81M | – |
| Q3 FY2016 | Sep 30, 2016 | $40.78M | – |
See a number that looks wrong?